ABBV

AbbVie Inc

$296.22+$5.43+1.87%Price as of Oct 30, 2026, 12:22 PM ET

Key stats

Market cap: 523B
Open: —
Day range: —
52-week range: $190.75 – $303.99
Volume: 2.33M
Avg volume: 5.17M

Earnings

Q3 FY26Miss

Expected$3.83

Actual$3.82

Q2 FY26

Actual$2.03

Q1 FY26

Actual$0.39

Q4 FY25

Actual$1.02

About

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Employees: 57,000
Headquarters: North Chicago, IL